evipedia.ai
← Back

Vitamin C for Health & Longevity

Created on 11/04/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Vitamin C, an essential nutrient widely taken as a dietary supplement for colds and health optimization, reliably prevents deficiency. Taken daily, it modestly shortens colds, slightly lowers blood pressure and slightly improves blood sugar control in diabetes. Large long-term trials in well-nourished adults found no fewer heart attacks, cancers or deaths. High doses bring risks, including kidney stones in men; diet-level to moderate intake captures most documented value. (Full Review)

Protocol

Food-first baseline
About 200 mg/day
From five servings of fruit and vegetables; approaches plasma saturation, no evident value above 400 mg/day
Trial-tested supplement dose
500 mg/day
Used for about eight to nine years in large prevention trials of men and women
Half-life and dose splitting
Two or three daily doses
Plasma half-life near 2 hours after high doses; splitting keeps levels steadier than one large dose
Time to effect
Plasma vitamin C
Days to weeks
Rises within days of a dose change; steady state over weeks
Common colds
Across a season
Benefits appear with regular use, not when started at cold onset
Blood pressure
6–8 weeks
Median length of the blood pressure trials

Benefits

Contraindications
  • G6PD deficiency: IV doses above the Recommended Dietary Allowance and multi-gram oral doses
  • History of calcium oxalate kidney stones or hyperoxaluria: high-dose supplements
  • Renal impairment, including dialysis: high-dose oral or IV vitamin C
  • Iron overload treated with deferoxamine plus heart failure: combined use; without heart failure, above 200 mg/day
  • Hereditary hemochromatosis not on chelation: high-dose supplements
  • Septic shock on vasopressors: IV vitamin C at 50 mg/kg every 6 hours
  • Pregnancy and lactation: IV doses above the Recommended Dietary Allowance
    •
Key Interactions
  • Statin plus niacin (e.g., simvastatin): blunted benefit with an antioxidant mix including 1,000 mg vitamin C
  • Levothyroxine: improved absorption (hypothyroid patients with gastritis)
  • Amphetamine and urine pH-sensitive drugs (e.g., fluphenazine): lower blood levels and effect
  • Antibiotics (erythromycin, doxycycline, streptomycin, kanamycin, lincomycin): may decrease their activity
  • Iron supplements (e.g., ferrous sulfate): increased non-heme iron absorption
  • Vitamin E and other antioxidant supplements (additive): blunted mitochondrial training adaptation
  • Glucose meters and continuous glucose monitors: falsely raised readings
  • Indinavir: lower drug levels (1,000 mg/day)
  • Propranolol: lower drug levels and heart-rate effect (2 g; judged of little biological importance)
  • Nitrates (e.g., nitroglycerin): prevented nitrate tolerance
  • Levodopa: raised absorption (only with poor baseline absorption; 200 mg)
  • Cyclosporine: lower drug levels (vitamin C plus E)
  • Proton pump inhibitors (such as omeprazole): lower plasma vitamin C
  • Aspirin: lower plasma vitamin C (0.8 g three times daily)
  • Aluminum-containing antacids (e.g., aluminum hydroxide): increased aluminum absorption
  • Itraconazole: increased drug bioavailability (acidic vitamin C beverage)
    •
Theoretical (inferred from mechanism)
  • Bortezomib: reduced efficacy
  • High-dose N-acetylcysteine and other antioxidants: may blunt training adaptation
    •

Risk & Side Effects

  • High:
  • Medium: Kidney stones in men
    •
  • Low: Higher cardiovascular mortality in postmenopausal women with diabetes; age-related cataract with high-dose supplements; harm with high-dose IV vitamin C in septic shock; blunted endurance-training adaptations; oxalate nephropathy with very high doses; hemolysis in glucose-6-phosphate dehydrogenase deficiency; gastrointestinal upset at multi-gram oral doses; infusion reactions with high-dose IV use; false glucose and laboratory readings; iron accumulation in hemochromatosis
    •
  • Speculative:

Monitoring

Marker Target Why
Plasma vitamin C About 60–80 µmol/L Confirms repletion
Serum creatinine 0.7–1.3 mg/dL in men, 0.6–1.1 mg/dL in women Safety check; rising values stop high-dose use
24-hour urine oxalate Below 40 mg/24 h Safety check; a rise changes or stops use
G6PD activity Normal enzyme activity Safety check; deficiency rules out high doses
Serum ferritin About 24–336 ng/mL in men, 11–307 ng/mL in women Safety check; high values change use
HbA1c (in type 2 diabetes) About 4.0–5.6% Expected to change
Blood pressure (in hypertension) No established target for vitamin C response; track change from own baseline Expected to change
Serum uric acid (with gout or high urate) 3.4–7.0 mg/dL in men, 2.4–6.0 mg/dL in women Expected to change

Cadence: Baseline before supplements above about 500 mg/day; recheck 4–8 weeks after starting or changing the dose, then every 6–12 months on stable intake. Before any IV course, kidney function and G6PD status, with creatinine repeated during the course.

Qualitative Assessment

  • Frequency, duration and severity of colds, especially during heavy training or travel
  • Gastrointestinal tolerance (bloating, loose stools) at the current dose
  • Deficiency signs: easy bruising, bleeding gums, slow wound healing, fatigue
  • Exercise-related cough or wheeze in athletes
  • Flank pain, blood in the urine or dark urine as warning signs
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.